Immuron Limited American Depositary Shares — gráfico, cotizaciones y noticias (NASDAQ:IMRN)

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Trimestre Año

Market Capitalization 4.97 M
Employee 7
Founded 1994
CEO N/A
Website www.immuron.com.au
Headquarter Australia
FIGI BBG000LZD9X8
Industry Technology

Deuda total

Flujo de caja libre

Efectivo y equivalentes

4.97 M Capitalización de mercado

Immuron Limited - American Depositary Shares

Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited. Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment. In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market.